Emergency Use Authorization (EUA) Revoked for ...
The FDA revoked the Emergency Use Authorization for bebtelovimab, 175mg, effective November 30, 2022. This monoclonal antibody treatment for COVID-19, including specific injection codes and administration details, was authorized from August 15, 2022, to November 30, 2022.
Reference News
Emergency Use Authorization (EUA) Revoked for ...
The FDA revoked the Emergency Use Authorization for bebtelovimab, 175mg, effective November 30, 2022. This monoclonal antibody treatment for COVID-19, including specific injection codes and administration details, was authorized from August 15, 2022, to November 30, 2022.